description E. Donnall Thomas Overview
American physician E. Donnall Thomas (1920-2012) helped establish bone marrow transplantation as a treatment for leukemia and other blood disorders. His work addressed the challenge of replacing a patient's blood-forming marrow after it had been destroyed by radiation or chemotherapy. At the Fred Hutchinson Cancer Research Center in Seattle, he developed transplantation methods involving the collection, storage, and infusion of donor marrow.
The treatment required more than transferring cells: donor compatibility and the interaction between the transplanted immune cells and the recipient were central problems. Thomas's research helped bring this approach into clinical practice, linking experimental work with the care of patients facing serious disease. He shared the 1990 Nobel Prize in Physiology or Medicine with Joseph Murray. His career is especially relevant to the history of oncology and the development of treatments based on replacing damaged tissues.
help E. Donnall Thomas FAQ
What did E. Donnall Thomas win the Nobel Prize for?
Thomas shared the 1990 Nobel Prize in Physiology or Medicine with Joseph E. Murray, recognized for his pioneering work in bone marrow transplantation as a treatment for leukemia and other blood disorders. The Nobel committee cited his development of methods for harvesting, preserving, and infusing bone marrow to replace a patient's diseased blood-forming cells after radiation or chemotherapy.
Where did Thomas conduct his bone marrow transplant research?
Thomas conducted much of his landmark work at the Fred Hutchinson Cancer Research Center in Seattle, Washington, where he moved in 1974. Earlier experiments with marrow transplants in dogs and human patients were carried out at the Mary Imogene Bassett Hospital in Cooperstown, New York, beginning in the mid-1950s.
What did Thomas's early bone marrow transplants involve?
Thomas's first successful human allogeneic bone marrow transplant was performed on a patient with aplastic anemia using marrow from a matched sibling donor. His team had to overcome graft-versus-host disease and graft rejection, major immunological barriers that took years of laboratory and clinical research to manage.
When did bone marrow transplantation become a standard treatment?
Thomas's methods gradually gained acceptance through the 1970s and 1980s as survival rates improved with better tissue-matching techniques and immunosuppressive drugs. By the time he received the Nobel Prize in 1990, bone marrow transplantation had become an established curative therapy for leukemia, lymphoma, and dozens of inherited metabolic and immune disorders.
explore Explore More
Reviews & Comments
Write a Review
Be the first to review
Share your thoughts with the community and help others make better decisions.
